The Leukemia and Bone Marrow Failure Program offers a comprehensive approach to acute and chronic leukemia, myeloproliferative syndromes (such as polycythemia vera and myelofibrosis), myelodysplastic syndromes and aplastic anemia.
Special Programs:
Myeloproliferative Disease Center provides comprehensive care and innovative research for patients with polycythemia, thrombocytosis, myelocibrosis and leukemia.
Innovative clinical trials involving newly developed drugs, biological therapies, and antibodies
